Many risks in clinical trials are therapy specific. Because of that, the currently available tools addressing those risks, like the TransCelerate Risk Assessment and Categorization Tools (RACTs), are now becoming therapy specific as well. The first therapy focused risk library Oncology RACT (OncoRACT) recently got available.
The OncoRACT library has emerged in response to the large number of challenges that today’s Oncology trials face. Specific subject safety risks, adjudication risks, therapy cycle risks, Oncology-specific outcomes and subject recruitment risks are explicitly addressed by OncoRACT.
Read more at ACT, publication: “Oncology therapy focused RACT emerges” by Moe Alsumidaie